Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Guy Weinberg
University of Illinois at Chicago, Department: Anesthesiology
Should you be removed from our database? Contact us at [email protected]. Read more below.
ResQ Pharma, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
NA
Intralipid: A novel frontline countermeasure for brodifacoum poisoning
There are no established protocols to deal with a mass casualty disaster following exposure to a superwarfarin such as brodifacoum; our studies will provide the necessary data to propose an IND to use intra osseous administration of a lipid emulsion as a first line method to exposed victims, thereby reducing mortality, subsequent neurological problems, and in utero abnormalities.
Filed on October 28, 2013.
Tell us what you know about Guy Weinberg's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Guy Weinberg”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Guy Weinberg | University of Illinois at Chicago | Conflict of Interest | ResQ Pharma, LLC | $40,000 - $59,999 |
| Guy Weinberg | University of Illinois at Chicago | Conflict of Interest | ResQ Pharma, LLC | Value cannot be readily determined |
| Guy Weinberg | University of Illinois at Chicago | Conflict of Interest | ResQ Pharma, Inc. | $10,000 - $19,999 |
| Guy Weinberg | University of Illinois at Chicago | Conflict of Interest | ResQ Pharma, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.